Wednesday, June 3, 2020

COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report

COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report Gilead Sciences#39; experimental drug Remdesivir has been found to aid in the recovery of COVID-19 patients.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-gilead-says-indian-licensees-free-to-price-remdesivir-report_13859421.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...